CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a fourth-quarter loss of $22.8 million, after reporting a profit in the same period a year earlier.
The Cambridge, Massachusetts-based company said it had a loss of 10 cents per share.
The kidney disease treatment developer posted revenue of $46.5 million in the period.
For the year, the company reported that its loss widened to $69.4 million, or 33 cents per share. Revenue was reported as $160.2 million.
The company’s shares closed at $1.93. A year ago, they were trading at $1.42.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
